| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 08/15/2006 | US7091398 Isolated sucrose sythase polynucleotides and uses thereof |
| 08/15/2006 | US7091397 Nucleic acid molecules encoding polypeptides having the enzymatic activity of an RNA-directed RNA polymerase (RdRP) |
| 08/15/2006 | US7091396 Animals, cells and methods for production of detectably-labeled antibodies |
| 08/15/2006 | US7091333 Oligomers that hybridize to Inhibition of Apoptosis (IAP) polynucleotides and methods for using them to enhance apoptosis and treat proliferative diseases |
| 08/15/2006 | US7091332 For expressing in mammalian cells microbial proteins that have anti-microbial, particularly anti-staphylococcal, activity; for therapy of mastitis in ruminant animals |
| 08/15/2006 | US7091330 Cloning and characterization of a CD2 binding protein (CD2BP2) |
| 08/15/2006 | US7091326 Fusion protein having enhanced in vivo erythropoietin activity |
| 08/15/2006 | US7091325 Fibrin/fibrinogen-binding conjugate |
| 08/15/2006 | US7091324 For diagnosis and therapy of HCV infection, including being useful in the identification of patients expected to benefit from certain therapeutic strategies |
| 08/15/2006 | US7091323 Human TIMP-1 antibodies |
| 08/15/2006 | US7091317 Enhanced green fluorescent protein for use as diagnostic tool in monitoring gene expression, function and localization |
| 08/15/2006 | US7091316 Protein induced by homogeneous blood transfusion and DNA encoding the same |
| 08/15/2006 | US7091312 Polypeptide comprising insecticidal and/or fungicidal activity for biological pest control; disease resistant plants; translational inhibition |
| 08/15/2006 | US7091179 Methods of use of fibroblast growth factor, vascular endothelial growth factor and related proteins in the treatment of acute and chronic heart disease |
| 08/15/2006 | US7091041 Micellar systems |
| 08/15/2006 | US7091040 P450/acetaminophen genetically directed enzyme prodrug therapy (GDEPT) |
| 08/15/2006 | US7091039 Kunitz domain polypeptide zkun6 |
| 08/15/2006 | US7091038 Ecdysone receptor-based inducible gene expression system |
| 08/15/2006 | US7091037 expression cassette comprising a promoter operably linked to a DNA segment encoding p95, preferably encoding a promoter operably linked to a DNA segment encoding a fusion polypeptide comprising Mre11 |
| 08/15/2006 | US7091032 Methylotrophic pichia for secretion of proinsulin; antidiabetic agents |
| 08/15/2006 | US7091031 nucleic acid molecules encoding enzymes useful for microbial production of cyclic hydroxylated carotenoid compounds; crtZ gene, isolated from Brevundimonas vesicularis DC263 |
| 08/15/2006 | US7091030 Composition for the preservation of viruses |
| 08/15/2006 | US7091029 Preparing adeno-associated viral vectors for gene therapeutic treatment of respiratory system disorders |
| 08/15/2006 | US7091028 Method for directed packaging of molecular substances in protein shells |
| 08/15/2006 | US7091027 Transgenic amorpha-4,11-diene synthesis |
| 08/15/2006 | US7091026 Synthetic peptide for use in the treatment of cancer, inflammation and infections |
| 08/15/2006 | US7091025 Malathion carboxylesterase |
| 08/15/2006 | US7091024 Enzyme PDE XVI |
| 08/15/2006 | US7091023 Polypeptides, capable of stereoselective hydrolysis of chiral feruloyl ester into ferulic acid and an alcohol |
| 08/15/2006 | US7091022 Mitogen activated kinase |
| 08/15/2006 | US7091019 The use of these proteins enables the transformation of a hop by gene manipulations as well as enables the in vitro synthesis of the secondary metabolites of a hop. |
| 08/15/2006 | US7091018 Enzyme gene and its expression product |
| 08/15/2006 | US7091014 Transformed microorganisms with improved properties |
| 08/15/2006 | US7091010 Biodegradable, resistant to salt, hardly forms spores, does not contain any plasmids; food and beverage additive; cosmetics |
| 08/15/2006 | US7091007 Comprises nucleotide sequences coding bone morphogenic and serine/threonine receptor proteins for for identifying modulators for use in prevention and treatment of bone and/or cartilage disorders |
| 08/15/2006 | US7091006 Isolated nucleic acid of given sequence; use in identifying metabolic and neurological disorders |
| 08/15/2006 | US7091005 Elongation of fatty acids(ELF) polypeptides and carrier mixtures administered for prophylaxis or prevention of vision defects |
| 08/15/2006 | US7091004 Regulation of translation for recombinant protein production |
| 08/15/2006 | US7091003 Polypeptides having phospholipase B activity and nucleic acids encoding same |
| 08/15/2006 | US7091002 Carboxypeptidases and nucleic acids encoding same |
| 08/15/2006 | US7091000 Bacterial strains which overproduce riboflavin and methods of use thereof |
| 08/15/2006 | US7090999 preparing pristinamycin IIA and/or IIB by introducing a disabling mutation into a gene that encodes 3-hydroxypicolinic acid:adenosine 5'-monopiosphate ligase; selecting and culturing cells containing the mutated gene that are blocked in the production of pristinamycin IA and IB |
| 08/15/2006 | US7090994 Methods of screening for introduction of DNA into a target cell |
| 08/15/2006 | US7090991 System for detection of a functional interaction between a compound and a cellular signal transduction component |
| 08/15/2006 | US7090986 identifying compounds such as antibodies that compete with the binding of Saratin to collagen by determining the binding of said Saratin to collagen in the presence or absence of a competitor. |
| 08/15/2006 | US7090980 Method of detecting acid-fast bacteria using ribosomal RNA as target |
| 08/15/2006 | US7090979 making very long, double-stranded synthetic poly-nucleotides by sequentially hybridizing short oligonucleotides to each other; enzymatic ligation of the oligonucleotides provides a contiguous piece of PCR-ready DNA of predetermined sequence. |
| 08/15/2006 | US7090978 Obtaining tissue or sample DNA or RNA from a potential tumor cell; Amplification by polymerase chain reaction; Southern hybridization or RNase A mismatch cleavage; useful in diagnosis and prognosis of cancer |
| 08/15/2006 | US7090976 Retroviral vector comprising green fluorescent reporter protein for use as diagnostic tool in genetic engineering |
| 08/15/2006 | US7090864 Non-invasive gene targeting to ocular cells |
| 08/15/2006 | US7090852 Virion protein; induce immunology response; genetic engineered Dna |
| 08/15/2006 | US7090850 Proteins in enteroaggregative Escherichia coli (EAEC) useful for diagnosis and therapy of EAEC infections |
| 08/15/2006 | US7090849 Babesia canis vaccine |
| 08/15/2006 | US7090843 immunotherapy; fusion proteins; antitumor agents; for treatment and prevention of hodgkin's disease |
| 08/15/2006 | US7090842 antigen-binding fragment comprises immunoglobulin variable region light chains and heavy chains, produced by hybridoma; fusion proteins |
| 08/15/2006 | US7090838 Eliminating off-flavor in water and/or fish; cyanobacteria; reduction of chlorophyll; improved storage stability |
| 08/15/2006 | US7090837 comprises attachment incompetent fusogenic polypeptide (lentivirus or influenza hemagglutinin) and heterologous targeting polypeptide (chimeric, with transmembrane cd40 domain); gag genes/proteins; pol genes/proteins; rev genes/proteins; gene therapy |
| 08/15/2006 | US7090834 which exhibit improved binding; site directed mutagenesis; host cells |
| 08/15/2006 | US7090775 Separation enantiomorph mixture; mixing with solvent; desolventizing |
| 08/15/2006 | US7090759 Apparatus and method for light-controlled electrokinetic assembly of particles near surfaces |
| 08/15/2006 | CA2258554C Method for providing dense particle compositions for use in transdermal particle delivery |
| 08/15/2006 | CA2182906C Highly specific surfaces for biological reactions, method of preparation and utilization |
| 08/11/2006 | CA2596448A1 Methods and compositions related to heightened apobec-1 related protein (arp) expression |
| 08/10/2006 | WO2006084249A2 Telomerase rna subunit and methods of use thereof |
| 08/10/2006 | WO2006084217A2 Rnai-mediated inhibition of ocular hypertension targets |
| 08/10/2006 | WO2006084209A2 Rnai expression constructs |
| 08/10/2006 | WO2006084027A2 Sipa-1 gene and sipa-1 inhibitor for the treatment, prevention, and diagnosis of cancer |
| 08/10/2006 | WO2006084006A1 Human antibodies against rabies and uses thereof |
| 08/10/2006 | WO2006084005A2 Emergence of a r-type ca2+channel(cav2.3) contributes to cerebral artery constriction following subarachnoid hemorrhage |
| 08/10/2006 | WO2006083995A1 Method for constructing eukaryotic cells having multiple genomic deletions and/or insertions |
| 08/10/2006 | WO2006083984A1 Papillomavirus l2 n-terminal peptides for the induction of broadly cross-neutralizing antibodies |
| 08/10/2006 | WO2006083945A2 Rnai-mediated inhibition of ocular targets |
| 08/10/2006 | WO2006083936A2 Anti-ephb2 antibodies and methods using same |
| 08/10/2006 | WO2006083800A2 Nucleic acid silencing of huntington's disease gene |
| 08/10/2006 | WO2006083797A2 Improving and protecting cell therapy for neurological disorders including parkinson's disease |
| 08/10/2006 | WO2006083721A2 Purification process for piasmid dna |
| 08/10/2006 | WO2006083342A1 Formation of polyampholytes in the presence of a polyion |
| 08/10/2006 | WO2006083315A2 Non-dividing donor cells for gene transfer |
| 08/10/2006 | WO2006083289A2 Methods and compositions for enhancement of immunity by in vivo depletion of immunosuppressive cell activity |
| 08/10/2006 | WO2006083276A2 Interferon-alpha polypeptides and conjugates |
| 08/10/2006 | WO2006083253A1 Site-specific serine recombinases and methods of their use |
| 08/10/2006 | WO2006083133A2 Human embryonic stem cell created from an oocyte and a somatic cell derived from non-identical individuals and a method for preparing the same |
| 08/10/2006 | WO2006083040A1 Method of detecting nucleic acid by using nucleic acid microarray |
| 08/10/2006 | WO2006083017A1 Method for separating and purifying nucleic acid |
| 08/10/2006 | WO2006082992A1 Method of constructing novel higher plant and mehtod of promoting the growth of higher plant |
| 08/10/2006 | WO2006082958A1 Method of retrovirus storage |
| 08/10/2006 | WO2006082916A1 Method of determining gene relating to favorable beef taste and texture |
| 08/10/2006 | WO2006082890A1 Method of inducing differentiation of embryo-stem cell into hepatocyte and hepatocyte induced by the method |
| 08/10/2006 | WO2006082866A1 METHOD FOR DETECTING p53 DYSFUNCTION, METHOD FOR MOLECULAR DIAGNOSIS OF CANCER AND METHOD FOR EVALUATING COMPOUND EFFECTIVE IN TREATING CANCER |
| 08/10/2006 | WO2006082851A1 Mucin relating to epiglycanin |
| 08/10/2006 | WO2006082826A1 METHOD OF IDENTIFYING PURKINJE CELL TARGETING Corl2 GENE |
| 08/10/2006 | WO2006082798A1 Monoclonal antibody specifically recognizing rat type i microglia |
| 08/10/2006 | WO2006082763A1 Method of regenerating elastic fiber with the use of dance or factor enhancing the expression thereof |
| 08/10/2006 | WO2006082685A1 Method for detecting single nucleotide polymorphism |
| 08/10/2006 | WO2006082398A2 Nucleic acid constructs |
| 08/10/2006 | WO2006082385A1 Screening method |
| 08/10/2006 | WO2006082338A1 Method for avian embryonic development in vitro and applications |
| 08/10/2006 | WO2006082304A2 Novel peptides which interact with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | WO2006082303A1 Motif of beclin protein which interacts with anti-apoptotic members of the family of bcl-2 proteins and use thereof |
| 08/10/2006 | WO2006082237A1 Transcription regulating nucleotide sequence from solanaceae triose-phosphate translocator genes and their use in plant expression cassettes |